Matches in DBpedia 2015-10 for { ?s ?p "Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company’s core focus is the development and commercialization of novel therapeutics based on RNA interference, or RNAi, for genetically defined diseases. Alnylam was founded in 2002 by Phillip Sharp, Paul Schimmel, Dave Bartel, Thomas Tuschl and Phillip Zamore."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Alnylam_Pharmaceuticals abstract "Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company’s core focus is the development and commercialization of novel therapeutics based on RNA interference, or RNAi, for genetically defined diseases. Alnylam was founded in 2002 by Phillip Sharp, Paul Schimmel, Dave Bartel, Thomas Tuschl and Phillip Zamore.".
- Alnylam_Pharmaceuticals comment "Alnylam Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company’s core focus is the development and commercialization of novel therapeutics based on RNA interference, or RNAi, for genetically defined diseases. Alnylam was founded in 2002 by Phillip Sharp, Paul Schimmel, Dave Bartel, Thomas Tuschl and Phillip Zamore.".